Five things to know:
1. Fourth quarter sales were up 11.8% year-over-year with $5.8 billion. Full-year sales were $20.5 billion, an 11.1% increase from 2022.
2. Orthopedic sales in the fourth quarter were $2.4 billion, an 11% increase year-over-year. Hip sales were $414 million, and knee sales were $630 million.
3. Spine sales in the fourth quarter were $318 million. For the full year, spine sales were $1.2 billion.
4. Full year orthopedic sales were $8.7 billion, up 10.5% compared to 2022. Medsurg and Neurotechnology sales in 2023 were $11.8 billion, up 11.5% compared to 2022.
5. Stryker expects to see 7.5% to 9% increases in 2024 revenue compared to 2023. This is based on procedural volumes, demand for capital products and “stabilizing macro-economic
environment,” according to a news release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
